durvalumab in combination with platinum-based chemotherapy (Imfinzi® in combination with platinum-based chemotherapy)
Application Details
HSE100095
26012
durvalumab in combination with platinum-based chemotherapy
Imfinzi® in combination with platinum-based chemotherapy
AstraZeneca
18/03/2026
31/03/2025
Application Status
Full Health Technology Assessment Commissioned by HSE
23/04/2026
Rapid Review Completed
22/04/2026
Pricing and Reimbursement Application Complete
18/03/2026
Rapid Review Commissioned
13/03/2026